PRESS RELEASE
4 November 2025

Federal Circuit Provides First Guidance on AIA Derivation Proceedings

SB
Smart & Biggar

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.
The United States Court of Appeals for the Federal Circuit issued its first decision relating to derivation proceedings under the America Invents Act (AIA).
Canada
The United States Court of Appeals for the Federal Circuit issued its first decision relating to derivation proceedings under the America Invents Act (AIA). Smart & Biggar Principal Joshua Spicer shares his insights on the Court’s approach to inventorship in this landmark case.
“The Board focused on who had been first-to-invent as opposed to who was first-to-conceive. But the court ruled that the error was harmless because the Board’s decision actually turned on who was first-to-conceive.”
-Joshua Spicer
Read the full article on IPHQ News, the IP news and insights platform of IPH Limited: Federal Circuit Provides First Guidance on AIA Derivation Proceedings.

Contributor

Smart & Biggar uncovers and maximizes intellectual property and technology assets for our clients. Today’s fast-paced innovation economy demands a higher level of expertise and attention to detail when it comes to IP strategy and protection. With over 125 lawyers, patent agents and trademark agents collaborating across five Canadian offices, Smart & Biggar is trusted by the world’s leading innovators to find value in their IP rights. As market leaders in IP, Smart & Biggar’s team is on the pulse when it comes to the latest developments and the wider industry changes that impact our clients. To stay informed, visit smartbiggar.ca/insights, including access to our RxIP Update (smartbiggar.ca/insights/rx-ip-updates), a monthly digest of the latest decisions and law surrounding the life sciences and pharmaceutical industries.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More